Chuck Grassley actually said...

The Prescription Pricing for the People bill requires the FTC to study pharmaceutical intermediaries, including vertical integration.

Something ought to get done this Congress, considering the fact that there is already a bill out of Judiciary, a bill out of Commerce.

The Pharmacy Benefit Manager (PBM) Transparency Act (S. 127) requires transparency reporting by PBMs to shine sunlight on prices and fees as...

In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the dru...